Two children with ADA deficiency are treated differently. ADA activity in their blood (as a percentage of normal) is measured after one treatment. A child stays healthy while activity is at least 15 per cent. (Hypothetical data.)
Child 1: enzyme replacement therapy (one injection at week 0)
| Week | 0 (just after injection) | 1 | 2 | 3 |
|---|---|---|---|---|
| ADA activity (%) | 60 | 30 | 15 | 7.5 |
Child 2: genetically engineered lymphocytes (one infusion at month 0)
| Month | 1 | 4 | 8 | 12 |
|---|---|---|---|---|
| ADA activity (%) | 40 | 30 | 15 | 5 |
(a) From the data, how often must each child be treated to stay healthy?
(b) Explain why the activity falls so much faster in Child 1, and why it still falls, though slowly, in Child 2.
(c) Calculate how many treatments each child would need over 4 years.

